Trial intelligence / Profile preview

Long-term Safety of Udenafil for Erectile Dysfunction

NCT01901640Phase 3Completed

Sponsor
Dong-A Pharmaceutical
Start
Nov 2011
Primary completion
Nov 2012
Modality
Small Molecules
01

Overview

A Phase 3 trial of udenafil in erectile dysfunction (ED), sponsored by Dong-A Pharmaceutical. Started Nov 2011; status: completed.

02

Drugs

udenafil
03

Conditions

erectile dysfunction (ED)

Beyond the preview

Go deeper on NCT01901640.

Study design, results and competitive context are available in the Gosset platform where reported.

Study design & results

Available in the Gosset platform where reported.

Competitive context

Available in the Gosset platform where reported.

Bring the full picture into focus.

See how Gosset can support your research on NCT01901640.

Gosset Free

Get started with Gosset.

Enter your corporate email.

Work email preferred.

Book a call